Singapore - English - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - fulvestrant - injection, solution - 50 mg/ml - fulvestrant 50 mg/ml

European Union - English - EMA (European Medicines Agency)

astrazeneca ab - fulvestrant - breast neoplasms - endocrine therapy, anti-estrogens - faslodex is indicated , as monotherapy for the treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:, , not previously treated with endocrine therapy, or, with disease relapse on or after adjuvant antiestrogen therapy, or disease progression on antiestrogen therapy., , , in combination with palbociclib for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer in women who have received prior endocrine therapy. , in pre- or perimenopausal women, the combination treatment with palbociclib should be combined with a luteinizing hormone releasing hormone (lhrh) agonist.,

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

astrazeneca uk ltd - fulvestrant - solution for injection - 50mg/1ml

European Union - English - EMA (European Medicines Agency)

mylan pharmaceuticals limited - fulvestrant - breast neoplasms - endocrine therapy - fulvestrant is indicated for the treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:not previously treated with endocrine therapy, orwith disease relapse on or after adjuvant anti-estrogen therapy, or disease progression on antiestrogen therapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - fulvestrant - solution for injection in pre-filled syringe - 250mg millilitre - anti-estrogens

Malta - English - Medicines Authority

teva b.v. swensweg 5, 2031 ga haarlem, netherlands - fulvestrant - solution for injection in a pre-filled syringe - fulvestrant 250 mg - endocrine therapy

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

astrazeneca uk ltd. - fulvestrant - solution for injection - 50mg/ml, (2) pre-filled syringes, (2) needles

Ireland - English - HPRA (Health Products Regulatory Authority)

ever valinject gmbh - fulvestrant - solution for injection in pre-filled syringe - 250 milligram(s) - fulvestrant

Singapore - English - HSA (Health Sciences Authority)

accord healthcare private limited - fulvestrant - injection, solution - fulvestrant 250 mg/5 ml

Singapore - English - HSA (Health Sciences Authority)

sandoz singapore pte. ltd. - fulvestrant - injection, solution - fulvestrant 250mg/5ml